These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 27491540)
1. Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor. Nojima H; Kanou K; Terashi G; Takeda-Shitaka M; Inoue G; Atsuda K; Itoh C; Iguchi C; Matsubara H BMC Struct Biol; 2016 Aug; 16():11. PubMed ID: 27491540 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin. Dong J; Gong Y; Liu J; Chen X; Wen X; Sun H Bioorg Med Chem; 2014 Feb; 22(4):1383-93. PubMed ID: 24457090 [TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2 Musoev A; Numonov S; You Z; Gao H Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858 [TBL] [Abstract][Full Text] [Related]
4. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors. Nongonierma AB; Mooney C; Shields DC; FitzGerald RJ Peptides; 2014 Jul; 57():43-51. PubMed ID: 24793774 [TBL] [Abstract][Full Text] [Related]
5. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation. Meduru H; Wang YT; Tsai JJ; Chen YC Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951 [TBL] [Abstract][Full Text] [Related]
7. Martins MCMR; Pantaleao SQ; de Oliveira Almeida M; Weber KC; Honorio KM Med Chem; 2021; 17(3):247-263. PubMed ID: 31995015 [TBL] [Abstract][Full Text] [Related]
8. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening. Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572 [TBL] [Abstract][Full Text] [Related]
9. Possible ligand release pathway of dipeptidyl peptidase IV investigated by molecular dynamics simulations. Li C; Shen J; Li W; Lu C; Liu G; Tang Y Proteins; 2011 Jun; 79(6):1800-9. PubMed ID: 21465558 [TBL] [Abstract][Full Text] [Related]
10. Hybrid docking-QSAR studies of DPP-IV inhibition activities of a series of aminomethyl-piperidones. Amini Z; Fatemi MH; Gharaghani S Comput Biol Chem; 2016 Oct; 64():335-345. PubMed ID: 27570070 [TBL] [Abstract][Full Text] [Related]
11. Understanding the molecular dynamics of type-2 diabetes drug target DPP-4 and its interaction with Sitagliptin and inhibitor Diprotin-A. Chakraborty C; Hsu MJ; Agoramoorthy G Cell Biochem Biophys; 2014 Nov; 70(2):907-22. PubMed ID: 24809328 [TBL] [Abstract][Full Text] [Related]
12. Anagliptin, a potent dipeptidyl peptidase IV inhibitor: its single-crystal structure and enzyme interactions. Watanabe YS; Yasuda Y; Kojima Y; Okada S; Motoyama T; Takahashi R; Oka M J Enzyme Inhib Med Chem; 2015 Dec; 30(6):981-8. PubMed ID: 26147347 [TBL] [Abstract][Full Text] [Related]
13. Comparative Binding Analysis of Dipeptidyl Peptidase IV (DPP-4) with Antidiabetic Drugs - An Ab Initio Fragment Molecular Orbital Study. Arulmozhiraja S; Matsuo N; Ishitsubo E; Okazaki S; Shimano H; Tokiwa H PLoS One; 2016; 11(11):e0166275. PubMed ID: 27832184 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors. Li Q; Han L; Zhang B; Zhou J; Zhang H Org Biomol Chem; 2016 Oct; 14(40):9598-9611. PubMed ID: 27714283 [TBL] [Abstract][Full Text] [Related]
15. A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site. Nabeno M; Akahoshi F; Kishida H; Miyaguchi I; Tanaka Y; Ishii S; Kadowaki T Biochem Biophys Res Commun; 2013 May; 434(2):191-6. PubMed ID: 23501107 [TBL] [Abstract][Full Text] [Related]
16. Discovery of tight-binding competitive inhibitors of dipeptidyl peptidase IV. Pascual Alonso I; Valiente PA; Valdés-Tresanco ME; Arrebola Y; Almeida García F; Díaz L; García G; Guirola O; Pastor D; Bergado G; Sánchez B; Charli JL Int J Biol Macromol; 2022 Jan; 196():120-130. PubMed ID: 34920066 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling. Rea D; Van Elzen R; De Winter H; Van Goethem S; Landuyt B; Luyten W; Schoofs L; Van Der Veken P; Augustyns K; De Meester I; Fülöp V; Lambeir AM Eur J Med Chem; 2017 Oct; 139():482-491. PubMed ID: 28826083 [TBL] [Abstract][Full Text] [Related]
18. DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of Kim BR; Kim HY; Choi I; Kim JB; Jin CH; Han AR Molecules; 2018 Aug; 23(8):. PubMed ID: 30103438 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors. Sharma M; Gupta M; Singh D; Kumar M; Kaur P Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro evaluation, and computational simulations studies of 1,2,3-triazole analogues as DPP-4 inhibitors. Vo DV; Hong KH; Lee J; Park H Bioorg Med Chem; 2021 Jan; 29():115861. PubMed ID: 33214038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]